Pharma R&D & Clinical Services · Indirect
Monitoring · monthly
Procurement Category Intelligence

Pharmacovigilance Services

PDF
Overview
Market size
6.7 billion
global, USD
CAGR
5.6%
base to forecast
Buyer power
-2.4
supplier-favoured
Suppliers
11
tracked players
Signals
12
1 high severity

Risk Exceptions

3
32United States21India1Japan1Poland1Germany11China1Brazil
7 countries · 0 lanes from 16 sourced statements

Buyer Power Score

-50+5
Negotiating position for this category, scored from supplier-favoured to buyer-favoured
-2.4 ⓘ
Equal to a supplier-favoured market into 2026 cover

Recommended stance. Build dual-source capability; negotiate MSA terms proactively

Catalysts & Deadlines

3
12 SignalsLive in the feed
12 ActionsRecommended
1 HighSeverity

Supplier Intelligence

11See all

Industry News

3

Related categories

Contract Research Organizations - PreclinicalContract Research Organizations - ClinicalClinical Trial Site ManagementClinical Data Management ServicesClinical Trial Patient RecruitmentDrug Safety MonitoringRegulatory Affairs ConsultingFDA Submission Support